Shanghai Shyndec Pharmaceutical Statistics

Total Valuation

Shanghai Shyndec Pharmaceutical has a market cap or net worth of CNY 17.01 billion. The enterprise value is 14.62 billion.

Market Cap	17.01B
Enterprise Value	14.62B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Sep 20, 2024

Share Statistics

Shanghai Shyndec Pharmaceutical has 1.34 billion shares outstanding. The number of shares has increased by 9.07% in one year.

Current Share Class	n/a
Shares Outstanding	1.34B
Shares Change (YoY)	+9.07%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	1.31%
Owned by Institutions (%)	9.35%
Float	542.49M

Valuation Ratios

The trailing PE ratio is 15.71 and the forward PE ratio is 12.68. Shanghai Shyndec Pharmaceutical's PEG ratio is 0.41.

PE Ratio	15.71
Forward PE	12.68
PS Ratio	1.48
PB Ratio	1.30
P/TBV Ratio	n/a
P/FCF Ratio	8.35
P/OCF Ratio	n/a
PEG Ratio	0.41

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.30, with an EV/FCF ratio of 7.18.

EV / Earnings	13.50
EV / Sales	1.27
EV / EBITDA	6.30
EV / EBIT	9.55
EV / FCF	7.18

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.07.

Current Ratio	2.51
Quick Ratio	1.61
Debt / Equity	0.07
Debt / EBITDA	0.49
Debt / FCF	0.56
Interest Coverage	40.65

Financial Efficiency

Return on equity (ROE) is 9.30% and return on invested capital (ROIC) is 6.04%.

Return on Equity (ROE)	9.30%
Return on Assets (ROA)	4.89%
Return on Capital (ROIC)	6.04%
Revenue Per Employee	990,814
Profits Per Employee	93,253
Employee Count	11,608
Asset Turnover	0.59
Inventory Turnover	3.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.63% in the last 52 weeks. The beta is 0.21, so Shanghai Shyndec Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+20.63%
50-Day Moving Average	11.78
200-Day Moving Average	10.86
Relative Strength Index (RSI)	57.29
Average Volume (20 Days)	24,844,279

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai Shyndec Pharmaceutical had revenue of CNY 11.50 billion and earned 1.08 billion in profits. Earnings per share was 0.81.

Revenue	11.50B
Gross Profit	4.38B
Operating Income	1.53B
Pretax Income	1.63B
Net Income	1.08B
EBITDA	2.31B
EBIT	1.53B
Earnings Per Share (EPS)	0.81

Full Income Statement

Balance Sheet

The company has 5.64 billion in cash and 1.13 billion in debt, giving a net cash position of 4.51 billion or 3.36 per share.

Cash & Cash Equivalents	5.64B
Total Debt	1.13B
Net Cash	4.51B
Net Cash Per Share	3.36
Equity (Book Value)	15.19B
Book Value Per Share	9.75
Working Capital	6.98B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.30 billion and capital expenditures -264.53 million, giving a free cash flow of 2.04 billion.

Operating Cash Flow	2.30B
Capital Expenditures	-264.53M
Free Cash Flow	2.04B
FCF Per Share	1.52

Full Cash Flow Statement

Margins

Gross margin is 38.09%, with operating and profit margins of 13.31% and 9.41%.

Gross Margin	38.09%
Operating Margin	13.31%
Pretax Margin	14.15%
Profit Margin	9.41%
EBITDA Margin	20.05%
EBIT Margin	13.31%
FCF Margin	17.70%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.57%.

Dividend Per Share	0.20
Dividend Yield	1.57%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	n/a
Payout Ratio	21.82%
Buyback Yield	-9.07%
Shareholder Yield	-7.50%
Earnings Yield	6.37%
FCF Yield	11.97%

Dividend Details

Stock Splits

The last stock split was on May 25, 2017. It was a forward split with a ratio of 2.

Last Split Date	May 25, 2017
Split Type	Forward
Split Ratio	2

Scores

Shanghai Shyndec Pharmaceutical has an Altman Z-Score of 3.41.

Altman Z-Score	3.41
Piotroski F-Score	n/a